Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving the cancer chemotherapy use process

D S Fischer1, S Alfano, M T Knobf

  • 1Yale New Haven Hospital, CT, USA.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achalasia in a Young Woman Thought to Have Had an Eating Disorder.

Irish medical journal·2022
Same author

Comparing the quantitative fit-testing results of half-mask respirators with various skin barriers in a crossover study design: a pilot study.

The Journal of hospital infection·2021
Same author

Animal and translational models of SARS-CoV-2 infection and COVID-19.

Mucosal immunology·2020
Same author

A Possible Cause of Kala-Azar.

The Indian medical gazette·2017
Same author

Piroplasmosis: A History of the Discovery of the Donovan Bodies in Madras.

The Indian medical gazette·2017
Same author

Piroplasma or Pyroplasma.

The Indian medical gazette·2017
Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

To prevent chemotherapy errors, hospitals are implementing specialized order writing, drug dispensing, and administration protocols. Most institutions now have processes in place to ensure safer cancer treatment.

Area of Science:

  • Oncology
  • Healthcare Management
  • Patient Safety

Background:

  • Erroneous cancer chemotherapy overdoses have severe consequences.
  • A review of institutional practices was prompted by these tragic events.
  • Practices at 123 other hospitals were also examined.

Purpose of the Study:

  • To review current in-house processes for preventing chemotherapy errors.
  • To identify opportunities for improving chemotherapy use.
  • To establish benchmarks for chemotherapy safety protocols.

Main Methods:

  • A multidisciplinary committee (oncologists, nurses, pharmacists) conducted the review.
  • A facsimile survey was distributed to members of the American Society of Clinical Oncology (ASCO).
  • 150 out of 215 ASCO members completed the survey.

Related Experiment Videos

Main Results:

  • 95% of hospitals have a process to prevent chemotherapy errors.
  • Cytotoxic chemotherapy orders are restricted to board-certified/eligible oncologists and fellows.
  • Drug dispensing is limited to oncology-certified pharmacists; administration by chemotherapy-certified nurses.

Conclusions:

  • Implementing these recommendations can improve chemotherapy safety and efficacy.
  • These measures aim to reduce the chemotherapy error rate significantly.
  • The goal is to achieve an error rate as close to zero as possible.